Incyte Corp (INCY)

Add to Watchlists
Create an Alert
66.06 +1.62  +2.51% NASDAQ Oct 19, 20:00 Delayed 2m USD

Incyte Corp Revenue (TTM):

1.729B for June 30, 2018
View 4,000+ financial data types
Browse...
View Full Chart

Incyte Corp Revenue (TTM) Chart

Export Data
Save Image
Print Image

Incyte Corp Historical Revenue (TTM) Data

View and export this data going back to 1993. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2018 1.729B
March 31, 2018 1.534B
Dec. 31, 2017 1.536B
Sept. 30, 2017 1.419B
June 30, 2017 1.306B
March 31, 2017 1.226B
Dec. 31, 2016 1.106B
Sept. 30, 2016 1.023B
June 30, 2016 941.24M
March 31, 2016 857.94M
Dec. 31, 2015 753.75M
Sept. 30, 2015 633.84M
June 30, 2015 644.38M
March 31, 2015 580.98M
Dec. 31, 2014 511.49M
Sept. 30, 2014 484.59M
June 30, 2014 371.57M
March 31, 2014 373.66M
Dec. 31, 2013 354.95M
Sept. 30, 2013 371.72M
June 30, 2013 347.09M
March 31, 2013 331.96M
Dec. 31, 2012 297.06M
Sept. 30, 2012 212.10M
June 30, 2012 168.39M
   
March 31, 2012 98.66M
Dec. 31, 2011 94.46M
Sept. 30, 2011 151.44M
June 30, 2011 151.53M
March 31, 2011 184.56M
Dec. 31, 2010 169.88M
Sept. 30, 2010 90.87M
June 30, 2010 74.94M
March 31, 2010 25.88M
Dec. 31, 2009 9.265M
Sept. 30, 2009 3.337M
June 30, 2009 3.459M
March 31, 2009 3.284M
Dec. 31, 2008 3.92M
Sept. 30, 2008 12.73M
June 30, 2008 18.36M
March 31, 2008 28.32M
Dec. 31, 2007 34.44M
Sept. 30, 2007 31.74M
June 30, 2007 32.32M
March 31, 2007 28.60M
Dec. 31, 2006 27.64M
Sept. 30, 2006 21.62M
June 30, 2006 15.58M
March 31, 2006 11.40M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Revenues

Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More

Advertisement

INCY Revenue (TTM) Benchmarks

Benchmarks
Regeneron Pharmaceuticals Inc 6.203B
Vertex Pharmaceuticals Inc 2.623B
Gilead Sciences Inc 23.20B

INCY Revenue (TTM) Range, Past 5 Years

Minimum 354.95M Dec 2013
Maximum 1.729B Jun 2018
Average 915.20M

INCY Revenue (TTM) Excel Add-In Codes

  • Metric Code: revenues_ttm
  • Latest data point: =YCP("INCY", "revenues_ttm")
  • Last 5 data points: =YCS("INCY", "revenues_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.